The technology which will print a working heart from a patient’s cells is been developing by Biolife4D Company. A few months later, a laboratory in Chicago will open, which can turn over the history of transplantology. The company consists of medical and science team. Founding partner and CEO is Steven Morris; Chief Medical Officer is Professor Jeffrey Morgan; Chief Science Officer is Dr. Ravi Birla, and Scientific Advisory Board is led by Dr. Adam Feinberg.
Read more HERE